Quantcast
Don't Miss
Home / Opinion Digests / Business Law / PTO Reversed on Cancer Treatment Patent (access required)

PTO Reversed on Cancer Treatment Patent (access required)

A foundation threated with the loss of its cancer treatment patent due to an unauthorized filing of a terminal disclaimer with the PTO wins its case against the PTO, as the Alexandria U.S. District Court reverses the PTO’s “arbitrary and capricious” refusal to withdraw the disclaimer. On Oct. 11, 2011, a terminal disclaimer of the subject ...

Print, Digital & Mobile

1 Month
$39

----------
6 Months
$199

----------
1 Year
$369

----------
2 Years
$659

----------
Digital & Mobile Only

1 Year
$299

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top